10 pending office actions • 10 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Charité – Universitätsmedizin Berlin | 1 |
| Securecell AG | 1 |
| Selexis S.A. | 1 |
| Ningaloo Biosystems GmbH | 1 |
| Hayne Lane Ltd. | 1 |
| C-Lecta GmbH | 1 |
| Agxx Intellectual Property Holding GmbH | 1 |
| Cellbox Solutions GmbH | 1 |
| Pl Bioscience GmbH | 1 |
| Selexis S.A. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18561751 | COMPUTER ASSISTED METHOD FOR THE EVALUATION OF CARDIAC METABOLISM | Charité – Universitätsmedizin Berlin | KHATTAR, RAJESH | 3684 | Final Rejection | Nov 17, 2023 |
| 18277298 | FLUID SAMPLING SYSTEM FOR BIOTECHNOLOGICAL APPLICATIONS, OPERATING METHOD AND USE THEREOF | Securecell AG | BOWERS, NATHAN ANDREW | 1799 | Non-Final OA | Aug 15, 2023 |
| 18351819 | EUKARYOTIC CELLS FOR PROTEIN MANUFACTURING AND METHODS OF MAKING THEM | Selexis S.A. | MONTANARI, DAVID A | 1632 | Non-Final OA | Jul 13, 2023 |
| 18249252 | DEVICE AND METHOD FOR CONTROLLING THE EXPOSURE OF A SAMPLE TO LIGHT | Ningaloo Biosystems GmbH | GROSS, ALEXANDER P | 2871 | Non-Final OA | Apr 16, 2023 |
| 18017133 | ECTOPARASITICIDE VETERINARY COMPOSITION | Hayne Lane Ltd. | PALENIK, JEFFREY T | 1615 | Final Rejection | Jan 20, 2023 |
| 18011258 | ONE-POT CELL-FREE GLYCOSYLATION PROCESS | C-Lecta GmbH | WHITE, ASHLEY TAYLOR | 1653 | Final Rejection | Dec 19, 2022 |
| 17926583 | BIOACTIVE COMPOSITION FOR KILLING CELLS | Agxx Intellectual Property Holding GmbH | VU, JAKE MINH | 1618 | Non-Final OA | Nov 28, 2022 |
| 17273854 | DEVICE FOR INCUBATING CULTURES, METHOD FOR INCUBATING CULTURES AND USE | Cellbox Solutions GmbH | HURST, JONATHAN M | 1799 | Non-Final OA | Mar 05, 2021 |
| 16305910 | METHOD FOR PRODUCING A PLATELET-LYSATE-CONTAINING GEL | Pl Bioscience GmbH | PYLA, EVELYN Y | 1633 | Non-Final OA | Nov 30, 2018 |
| 15561524 | EXPRESSION SYSTEM AND USES THEREOF | Selexis S.A. | RAMIREZ, DELIA M | 1652 | Non-Final OA | Sep 26, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial